Electronic Tool Helps Pharmacists Manage Asthma Care
Tests an electronic asthma tool used by pharmacists to guide asthma care for patients.
Plain-language title generated from the registry record
Registry title: The Electronic Asthma Management System in Pharmacies
Key facts
- Where
- Ajax, Niagara Falls, and Waterloo, CanadaSee the 3 sites
Where in Canada
- Medical Place PharmacyAjax, CanadaNo longer taking part
- LiveWell PharmacyNiagara Falls, CanadaNo longer taking part
- Westmount Place PharmacyWaterloo, CanadaNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Unity Health Toronto
- Trial code
- NCT07038642
- Record updated
- 17 August 2025
- Original description
The goal of this study is to assess the effect of an electronic asthma management system in pharmacies (eAMS-Pharm) on asthma control assessment, asthma medication adjustment, asthma action plan delivery, and prompting for specialist referral in severe asthma. The study assesses the differences on pharmacy processes (affecting both the pharmacy team and patients) and pharmacy-delivered care using an interrupted time-series analysis (six-months before vs. six-months after the introduction of eAMS-Pharm in study pharmacy sites).Read full original descriptionShow less
The Electronic Asthma Management System in Pharmacies (eAMS-Pharm)
The goal of this study is to assess the effect of an electronic asthma management system in pharmacies (eAMS-Pharm) on asthma control assessment, asthma medication adjustment, asthma action plan delivery, and prompting for specialist referral in severe asthma. The study assesses the differences on pharmacy processes (affecting both the pharmacy team and patients) and pharmacy-delivered care using an interrupted time-series analysis (six-months before vs. six-months after the introduction of eAMS-Pharm in study pharmacy sites).
The eAMS-Pharm uses patient data (asthma control, asthma flare-up risk, and current medications) to provide clinical decision support to pharmacists, empowering them to bridge existing gaps between guideline-recommended asthma care and patient care received.
Eligible patients would be those who have asthma and are seen at one of the three study pharmacies during the study period; Eligible pharmacy team members would be staff (pharmacists/RPhTs/assistants/students) at any one of the three study pharmacies.